This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Peptcell Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Gregory Alan Soloff: Innovator in Peptide Technology
Introduction
Gregory Alan Soloff is a notable inventor based in London, GB. He has made significant contributions to the field of peptide technology, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a key figure in the scientific community.
Latest Patents
Gregory Alan Soloff holds a patent for "Peptide sequences and compositions." This patent describes a polypeptide comprising no more than 100 amino acids, which includes sequences with at least 60% homology with specific sequences identified as SEQ ID 1-6. The polypeptide is designed to be immunogenic in vertebrates expressing a major histocompatibility complex (MHC) allele, while not being a complete influenza virus protein.
Career Highlights
Throughout his career, Soloff has focused on advancing the understanding and application of peptide sequences in immunology. His work has implications for vaccine development and therapeutic interventions, showcasing his commitment to improving health outcomes through scientific innovation.
Collaborations
Gregory Alan Soloff collaborates with Wilson Romero Capparros-Wanderlay, further enhancing the research and development efforts at Peptcell Limited. Their partnership exemplifies the importance of teamwork in driving scientific advancements.
Conclusion
Gregory Alan Soloff's contributions to peptide technology through his patent and collaborative efforts highlight his role as an influential inventor in the field. His work continues to pave the way for future innovations in immunology and related disciplines.